ATE399866T1 - Apoptosis induzierendes protein und dieses kodierendes gen - Google Patents

Apoptosis induzierendes protein und dieses kodierendes gen

Info

Publication number
ATE399866T1
ATE399866T1 AT97917435T AT97917435T ATE399866T1 AT E399866 T1 ATE399866 T1 AT E399866T1 AT 97917435 T AT97917435 T AT 97917435T AT 97917435 T AT97917435 T AT 97917435T AT E399866 T1 ATE399866 T1 AT E399866T1
Authority
AT
Austria
Prior art keywords
apoptosis
gene encoding
inducing protein
kinase activity
protein
Prior art date
Application number
AT97917435T
Other languages
English (en)
Inventor
Kohei Miyazono
Hidenori Ichijo
Original Assignee
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26459470&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE399866(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Japan Found Cancer filed Critical Japan Found Cancer
Application granted granted Critical
Publication of ATE399866T1 publication Critical patent/ATE399866T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97917435T 1996-04-19 1997-04-18 Apoptosis induzierendes protein und dieses kodierendes gen ATE399866T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12232096 1996-04-19
JP24106396A JP3839103B2 (ja) 1996-04-19 1996-08-23 アポトーシス誘導タンパク質およびそれをコードする遺伝子

Publications (1)

Publication Number Publication Date
ATE399866T1 true ATE399866T1 (de) 2008-07-15

Family

ID=26459470

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97917435T ATE399866T1 (de) 1996-04-19 1997-04-18 Apoptosis induzierendes protein und dieses kodierendes gen

Country Status (7)

Country Link
US (1) US6194187B1 (de)
EP (1) EP0896055B1 (de)
JP (1) JP3839103B2 (de)
AT (1) ATE399866T1 (de)
AU (1) AU2576397A (de)
DE (1) DE69738803D1 (de)
WO (1) WO1997040143A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040912A1 (en) * 1998-02-11 1999-08-19 The Brigham And Women's Hospital, Inc. Method of stimulating apoptosis using trichothecene mycotoxins
US6080546A (en) * 1999-07-23 2000-06-27 Isis Pharmaceuticals Inc. Antisense modulation of MEKK5 expression
US20030224378A1 (en) * 2001-04-10 2003-12-04 Plowman Gregory D. Novel human protein kinases and protein kinase-like enzymes
JPWO2002038179A1 (ja) * 2000-11-10 2004-03-11 キッセイ薬品工業株式会社 小胞体ストレス関連疾患の予防又は治療剤
WO2003063905A1 (fr) * 2002-01-31 2003-08-07 Center For Advanced Science And Technology Incubation, Ltd. Medicaments preventifs ou remedes pour maladies immunologiques
AU2003294668A1 (en) * 2002-09-06 2004-04-08 Institut Curie Use of inhibitors of compounds involved in the jun kinase (jnk) biochemical cellular pathway for the treatment or diagnosis of liposarcomas
AU2003284597A1 (en) * 2002-11-22 2004-06-18 Takeda Pharmaceutical Company Limited Apoptosis-associated protein and use thereof
JP4488720B2 (ja) * 2002-11-22 2010-06-23 武田薬品工業株式会社 アポトーシス関連蛋白質およびその用途
JPWO2005009470A1 (ja) * 2003-07-28 2006-09-28 財団法人大阪産業振興機構 Ａｓｋ１阻害剤を有効成分とする心不全治療薬およびそのスクリーニング方法
WO2005103288A1 (ja) 2004-04-27 2005-11-03 Takeda Pharmaceutical Company Limited スクリーニング方法
WO2005114199A1 (en) * 2004-05-13 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 5 (map3k5)
WO2009030094A1 (fr) * 2007-09-06 2009-03-12 Zhejiang University Fonction et utilisation d'une nouvelle protéine induisant une apoptose associée aux lysosomes contenant les domaines ph et fyve (lapf)
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
ES2445917T3 (es) 2010-02-03 2014-03-06 Takeda Pharmaceutical Company Limited Inhibidores de quinasa 1 reguladora de la señal de apoptosis
US10654833B2 (en) 2018-06-28 2020-05-19 Hepatikos Therapeutics, Llc ASK1 isoindolin-1-one inhibitors and methods of use thereof

Also Published As

Publication number Publication date
EP0896055A4 (de) 2004-05-12
EP0896055B1 (de) 2008-07-02
DE69738803D1 (de) 2008-08-14
EP0896055A2 (de) 1999-02-10
AU2576397A (en) 1997-11-12
JPH1093A (ja) 1998-01-06
JP3839103B2 (ja) 2006-11-01
US6194187B1 (en) 2001-02-27
WO1997040143A1 (fr) 1997-10-30

Similar Documents

Publication Publication Date Title
ATE399866T1 (de) Apoptosis induzierendes protein und dieses kodierendes gen
PT797676E (pt) Vector adenoviral recombinante e metodos de utilizacao
FI960089A (fi) Proteiinikinaasi C:n oligonukleotidimodulaatio
HK1031836A1 (en) Methods of modulating serine/threonine protein kinase function with 5-azaquinoxa-line-based compounds.
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
NO962188D0 (no) Nye apoptose-modulerende proteiner, DNA som koder for proteinene og fremgangsmåter for anvendelse derav
CY1106198T1 (el) Γονιδιακη θepαπεια που διαμεσολαβειται απο αδενοϊο
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
FI905660A0 (fi) Nya polypeptider, dna-sekvenser som moejliggoer deras expression, foerfarande foer framstaellning och anvaendning.
DE68917556D1 (de) Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren.
DE69333954D1 (de) An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung
DE68916705D1 (de) Ringsubstituierte 2-Amin-1,2,3,4-tetrahydro-naphthaline.
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
GR3015239T3 (en) Peptide with anti-metastasis activity.
DE69838810D1 (de) Gen von alteromonas
ATE78029T1 (de) Propanaminderivate.
DE69943184D1 (de) Identifizierung und funktionelle charakterisierung einer ribosomalen s6 proteinkinase
FI962558A0 (fi) Uusi kasvainsuppressorigeeni
DE59000772D1 (de) Seitenstaendige carbazolyl-gruppen enthaltende methacrylat-(co)polymerisate und elektrophotographische aufzeichnungselemente, enthaltend dieselben.
IT8921360A0 (it) Stabilizzatore aminico polimerico per spandex.
ATE320496T1 (de) Testisspezifische, menschliche proteinase, svph1- 8
DE68917536D1 (de) Methode zur Reduktion von aromatischen Amino-Gruppen.
DE69738945D1 (de) Rken
IL132632A0 (en) Dna encoding a gilr protein the protein its preparation and use
GB2217325B (en) Synthetic gene for tumour necrosis factor alpha.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties